Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia

  • Mauricio Arruda
  • Luciana Armaganijan
  • Tamer Fahmy
  • Luigi Di Biase
  • Dimpi Patel
  • Andrea Natale


Arrhythmogenic right ventricular dysplasia (ARVD) is a progressive, genetically determined fibro-fatty infiltrative myocardial disease with an estimated prevalence in the general population to be 1:5,000 to 1:10,000. ARVD leads to electrical instability that may predispose to life-threatening ventricular arrhythmia, heart failure, and sudden death. We reviewed the pathological substrate for ventricular arrhythmias, ECG findings and treatment modalities in ARVD. Importantly, novel techniques such as electroanatomic and voltage mapping has greatly improved the identification of the scared substrate in the settings of ARVD and have improved safety and efficacy of VT ablation procedures associated with this entity.


Catheter ablation Arrhythmogenic right ventricular dysplasia ARVD Ablation in arrhythmogenic right ventricular dysplasia 


  1. 1.
    Fontaine, G., Gallais, Y., Fornes, P., et al. (2001). Arrhythmogenic right ventricular dysplasia cardio myopathy. Anesthesiology, 95(1), 250–254.PubMedCrossRefGoogle Scholar
  2. 2.
    Gemayel, C., Pelliccia, A., & Thompson, P. D. (2001). Arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 38(7), 1773–1781.PubMedCrossRefGoogle Scholar
  3. 3.
    Thiene, G., Basso, C., Calabrese, F., et al. (2000). Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Herz, 25(3), 210–215.PubMedCrossRefGoogle Scholar
  4. 4.
    Corrado, D., Thiene, G., Nava, A., et al. (1990). Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. The American Journal of Medicine, 89(5), 588–596.PubMedCrossRefGoogle Scholar
  5. 5.
    Nava, A., Thiene, G., Canciani, B., et al. (1988). Familial occurrence of right ventricular dysplasia: a study involving nine families. Journal of the American College of Cardiology, 12(5), 1222–1228.PubMedCrossRefGoogle Scholar
  6. 6.
    Hulot, J. S., Jouven, X., Empana, J. P., et al. (2004). Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation, 110(14), 1879–1884.PubMedCrossRefGoogle Scholar
  7. 7.
    Tabib, A., Loire, R., & Miras, A. (2000). Unsuspected cardiac lesions associated with sudden unexpected perioperative death. European Journal of Anaesthesiology, 17, 230–235.PubMedGoogle Scholar
  8. 8.
    Ahmad, F. (2003). The molecular genetics of arrhythmogenic right ventricular dysplasia–cardiomyopathy. Clinical and Investigative Medicine, 26(4), 167–178.PubMedGoogle Scholar
  9. 9.
    Fontaine, G., Fontaliran, F., Hebert, J. L., et al. (1999). Arrhythmogenic right ventricular dysplasia. Annual Review of Medicine, 50, 17–35.PubMedCrossRefGoogle Scholar
  10. 10.
    Corrado, D., Basso, C., Thiene, G., et al. (1997). Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. Journal of the American College of Cardiology, 30(6), 1512–1520.PubMedCrossRefGoogle Scholar
  11. 11.
    Burke, A. P., Farb, A., Tashko, G., et al. (1998). Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases. Circulation, 97(16), 1571–1580.PubMedGoogle Scholar
  12. 12.
    Fontaine, G., Fontaliran, F., Zenati, O., et al. (1999). Fat in the heart. A feature unique to the human species? Observational reflections on an unsolved problem. Acta Cardiologica, 54(4), 189–184.PubMedGoogle Scholar
  13. 13.
    Jaoude, S. A., Leclercq, J. F., & Coumel, P. (1996). Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. European Heart Journal, 17(11), 1717–1722.PubMedGoogle Scholar
  14. 14.
    Nasir, K., Bomma, C., Tandri, H., et al. (2004). Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation, 110(12), 1527–1534.PubMedCrossRefGoogle Scholar
  15. 15.
    Turrini, P., Corrado, D., Basso, C., et al. (2001). Dispersion of ventricular depolarization–repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation, 103(25), 3075–3080.PubMedGoogle Scholar
  16. 16.
    Wichter, T., Borggrefe, M., Haverkamp, W., et al. (1992). Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation, 86(1), 29–37.PubMedGoogle Scholar
  17. 17.
    Priori, S. G., Aliot, E., Blomstrom-Lundqvist, C., et al. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. European Heart Journal, 22(16), 1374–1450.PubMedCrossRefGoogle Scholar
  18. 18.
    Hodgkinson, K. A., Parfrey, P. S., Bassett, A. S., et al. (2005). The impact of implantable cardioverter defibrillatortherapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD). Journal of the American College of Cardiology, 45(3), 400–408.PubMedCrossRefGoogle Scholar
  19. 19.
    Wichter, T., Paul, T. M., Eckardt, L., et al. (2005). Arrhythmogenic right ventricular cardiomyopathy antiarrhythmic drugs, catheter ablation, or ICD. Herz, 30(2), 91–101.PubMedCrossRefGoogle Scholar
  20. 20.
    Boulos, M., Lashevsky, I., Reisner, S., et al. (2001). Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. Journal of the American College of Cardiology, 38(7), 2020–2027.PubMedCrossRefGoogle Scholar
  21. 21.
    Boulos, M., Lashevsky, I., & Gepstein, L. (2005). Usefulness of electroanatomical mapping to differentiate between right ventricular outflow tract tachycardia and arrhythmogenic right ventricular dysplasia. The American Journal of Cardiology, 95(8), 935–940.PubMedCrossRefGoogle Scholar
  22. 22.
    Marchlinski, F. E., Zado, E., Dixit, S., et al. (2004). Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation, 110(16), 2293–2298.PubMedCrossRefGoogle Scholar
  23. 23.
    Fontaine, G., Tonet, J., Gallais, Y., et al. (2000). Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Current Cardiology Reports, 2(6), 498–506.PubMedCrossRefGoogle Scholar
  24. 24.
    Dalal, D., Jain, R., Tandri, H., Dong, J., Eid, S., Prakasa, K., et al. (2007). Long-term of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 432–440.PubMedCrossRefGoogle Scholar
  25. 25.
    Verma, A., Kilicaslan, F., Schweikert, R., Tomassoni, G., Rossillo, A., Marrouche, N., et al. (2005). Short and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation, 111, 3209–3216.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Mauricio Arruda
    • 1
  • Luciana Armaganijan
    • 3
  • Tamer Fahmy
    • 4
  • Luigi Di Biase
    • 2
  • Dimpi Patel
    • 2
  • Andrea Natale
    • 2
  1. 1.Electrophysiology SectionUniversity Hospitals Harrington-McLaughlin Heart and Vascular Institute, Case Western Reserve University School of MedicineClevelandUSA
  2. 2.Texas Cardiac Arrhythmias InstituteAustinUSA
  3. 3.Hamilton Health SciencesHamiltonCanada
  4. 4.Department of Critical Care MedicineCairo UniversityCairoEgypt

Personalised recommendations